Zai Lab Ownership
| ZLAB Stock | USD 37.17 0.60 1.59% |
Shares in Circulation | First Issued 2020-03-31 | Previous Quarter 99 M | Current Value 108 M | Avarage Shares Outstanding 93.2 M | Quarterly Volatility 8.6 M |
Zai Stock Ownership Analysis
About 52.0% of the company outstanding shares are owned by institutional investors. The company recorded a loss per share of 2.5. Zai Lab had not issued any dividends in recent years. Zai Lab Limited develops and commercializes therapies to treat oncology, autoimmune disorders, infectious diseases, and neuroscience primarily in Mainland China and Hong Kong. Zai Lab Limited was incorporated in 2013 and is headquartered in Shanghai, China. Zai Lab operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 1951 people. For more information please call the company at 86 21 6163 2588 or visit https://www.zailaboratory.com.Besides selling stocks to institutional investors, Zai Lab also allocates a substantial amount of its earnings to a pull of share-based compensation to be paid out to its employees, managers, executives, and members of the board of directors. Share-Based compensation (also sometimes called Stock-Based Compensation) is a way of paying different Zai Lab's stakeholders with equity in the business. It is typically used as a motivation factor for employees to contribute beyond their regular compensation (salary and bonus). It is also used as a tool to align Zai Lab's strategic interests with those of the company's shareholders. Shares issued to employees are usually subject to a vesting period before they are earned and sold.
Zai Lab Quarterly Liabilities And Stockholders Equity |
|
Zai Lab Insider Trades History
Only 1.42% of Zai Lab are currently held by insiders. Unlike Zai Lab's institutional investors, corporate insiders most likely have a limit on the maximum percentage of share ownership. This is done to align insiders' influence against Zai Lab's private investors even though both sides will benefit from rising prices or experience loss when the share price declines. The good rule to have in mind is that the maximum share ownership percentage of the corporate insiders should not surpass 25%. View all of Zai Lab's insider trades
Zai Stock Institutional Investors
Have you ever been surprised when a price of an equity instrument such as Zai Lab is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Zai Lab backward and forwards among themselves. Zai Lab's institutional investor refers to the entity that pools money to purchase Zai Lab's securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
| Shares | Bamco Inc | 2025-03-31 | 1.8 M | Ra Capital Management, Llc | 2025-03-31 | 1.3 M | Woodline Partners Lp | 2025-03-31 | 1.2 M | Connor Clark & Lunn Inv Mgmt Ltd | 2025-03-31 | 1 M | Adar1 Capital Management Llc | 2025-03-31 | 940.9 K | Rock Springs Capital Management Lp | 2025-03-31 | 904.6 K | Mpm Oncology Impact Management Lp | 2025-03-31 | 833.7 K | Jennison Associates Llc | 2025-03-31 | 712.3 K | Blackrock Inc | 2025-03-31 | 515.2 K | Fmr Inc | 2025-03-31 | 6.4 M | Capital World Investors | 2025-03-31 | 6 M |
Zai Lab Insider Trading Activities
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Zai Lab insiders, such as employees or executives, is commonly permitted as long as it does not rely on Zai Lab's material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases Zai Lab insiders are required to file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Zai Lab Outstanding Bonds
Zai Lab issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. Zai Lab uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most Zai bonds can be classified according to their maturity, which is the date when Zai Lab has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
Zai Lab Corporate Filings
F4 | 7th of July 2025 The report filed by a party regarding the acquisition or disposition of a company's common stock, as well as derivative securities such as options, warrants, and convertible securities | ViewVerify |
8K | 18th of June 2025 Report filed with the SEC to announce major events that shareholders should know about | ViewVerify |
| 14th of May 2025 Other Reports | ViewVerify | |
| 29th of April 2025 Other Reports | ViewVerify |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Zai Lab offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Zai Lab's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Zai Lab Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Zai Lab Stock:Check out Your Current Watchlist to better understand how to build diversified portfolios, which includes a position in Zai Lab. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For information on how to trade Zai Stock refer to our How to Trade Zai Stock guide.You can also try the Portfolio Backtesting module to avoid under-diversification and over-optimization by backtesting your portfolios.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Zai Lab. If investors know Zai will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Zai Lab listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (2.50) | Revenue Per Share | Quarterly Revenue Growth 0.222 | Return On Assets | Return On Equity |
The market value of Zai Lab is measured differently than its book value, which is the value of Zai that is recorded on the company's balance sheet. Investors also form their own opinion of Zai Lab's value that differs from its market value or its book value, called intrinsic value, which is Zai Lab's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Zai Lab's market value can be influenced by many factors that don't directly affect Zai Lab's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Zai Lab's value and its price as these two are different measures arrived at by different means. Investors typically determine if Zai Lab is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Zai Lab's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.